November 1, 2016
`
`CURRICULUM VITAE
`
`Daniel A. Bloch, Ph.D.
`
`BIRTHPLACE & DATE:
`
`Palo Alto, CA; January 15, 1941
`
`MARITAL STATUS:
`
`Married: Four children – born 1969, 72, 81, 85
`
`UNIVERSITY AFFILIATION:
`
`Stanford University School of Medicine
`Department of Health Research and Policy
`Division of Biostatistics
`Stanford, CA 94305-5405
`
`PRIMARY OFFICE:
`
`8987 E. Tanque Verde #309-387
`Tucson, AZ 85749
`Phone: (520) 749 1844
` Cell: (650) 996 4429
`
`1963:
`1967:
`
`EDUCATION:
`B.S. Stanford University, Major: Statistics
`Ph.D. Johns Hopkins University, Statistics
`
`ACADEMIC APPOINTMENTS:
`
`1967 - 1968
`
`1967-1969
`
`1969-1970
`
`1970 - 1972
`
`1984 - 1985
`
`Research Fellow, Biomathematics Department, Cornell University Medical
`School, New York, New York.
`
`Research Associate, Sloan-Kettering Institute for Cancer Research, New
`York, New York.
`
`Assistant Professor, Biomathematics Department, Cornell University
`Medical School, New York, NY
`Associate, Sloan-Kettering Institute for Cancer Research, New York, New
`York.
`
`Assistant Professor of Mathematics, California State University,
`Sonoma, Cotati, California.
`
`Statistician II. Division of Immunology, Department of Medicine, Stanford
`University, Stanford, California. Head Biostatistician
`for Arthritis,
`Rheumatism, and Aging Medical Information Systems (ARAMIS) and for
`Stanford Arthritis Center (SAC).
`
`1
`
`MYLAN - EXHIBIT 1043
`Mylan Pharmaceuticals Inc. et al. v. Allergan, Inc.
`IPR2016-01127, -01128, -01129, -01130, -01131, & -01132
`
`

`

`1985 - 1986
`
`1986 - 1993
`
`1993 - 1995
`
`Statistician III, Division of Immunology, Department of Medicine,
`Stanford University School of Medicine, Stanford, CA
`
`Senior Research Scholar, Department of Medicine, Stanford University
`School of Medicine, Stanford, California.
`
`Acting Associate Professor, Department of Medicine and Department of
`Health Research and Policy, Stanford University School of Medicine,
`Stanford, California.
`
`1995 – Sept. 2001
`
`Associate Professor of Health Research and Policy, Division of Biostatistics,
`Stanford University School of Medicine, Stanford, California.
`
`Sept. 2001 – present
`
`Professor of Health Research and Policy, Division of Biostatistics, Stanford
`University, Stanford, California. Emeritus since February, 2007.
`
`PROFESSIONAL APPOINTMENTS AND ACTIVITIES
`
`1. Research and Teaching Assistant, Statistics Department, Johns Hopkins University, Baltimore,
`Maryland, 1963 – 1967.
`
`2. Statistical Consultant, Stanford Linear Accelerator Center, Stanford, California, 1967.
`
`3. Owner, Daniel A. Bloch, dba Land House Construction, General Contractor “B”, License No.
`292149, 1972-1984.
`
`4. Member, Human Rights Committee, VA Cooperative Studies Center, 1986-1990.
`
`5. Head biostatistician for AIDS Time-Oriented Health Outcome Study (ATHOS), 1989-1995.
`
`6. Head biostatistician for the Stanford Arthritis Center (SAC), 1985-1996.
`
`7. Head biostatistician for Arthritis, Rheumatism, and Aging Medical Information Systems
`(ARAMIS) and for Stanford Arthritis Center (SAC), 1985-2000.
`
`8. Consultant on an ad hoc basis to pharmaceutical and biotechnical firms, 1987-present.
`
`9. Consultant to the VA Cooperative Studies Coordinating Center, 1990-2007.
`
`10. Member, Steering Committee, California Society of Addiction Medicine, 1990-1993.
`
`11. Special government employee: consultant to FDA (including FDA statistical advisors panel),
`1995-2006.
`
`12. Member, Database Advisory Steering Panel, National Multiple Sclerosis Society, 1997-2003.
`
`13. Member, Editorial Board for “Osteoarthritis and Cartilage”, 1998-2008.
`
`2
`
`

`

`14. Member, VA Combined Monitoring Board, 2002-2005.
`
`15. Member, Editorial Board for “Journal of Endovascular Therapy,” 2001-2008.
`
`16. Member, numerous DSMBs for private industry and NIH grants, 1993-present.
`
`SCHOLARLY PUBLICATIONS:
`
`1. Peer Reviewed Journal Articles
`
`1. Bloch DA. “A note on the estimation of the location parameter of Cauchy distribution.” J Am
`Stat Assoc, 1966; 61: 852-855.
`
`2. Bloch DA, Watson GS. “A Bayesian study of the multinomial distribution.” Ann Math Stat,
`1967; 38: 1423-1435.
`
`3. Bloch DA, Gastwirth JL. “On a simple estimate of the reciprocal of the density function.”
`Ann Math Stat, 1968; 39: 1083-1085.
`
`4. Wynder EL, Dodo H, Bloch DA, Gantt R, Moore O. “An epidemiological investigation of
`multiple primary cancers of the upper alimentary and respiratory tracts, I: a retrospective
`study.” Cancer, 1969; 730-739.
`
`5. Lincoff H, O’Conner P, Bloch DA, Nadel A, Kressig I, Grinberg M. “The cryosurgical
`adhesion, II.” Am Acad Opthalmol, 1970; 98-107.
`
`6. Bloch DA, O’Conner P, Lincoff H. “The mechanism of the cryosurgical adhesion III:
`statistical analysis.” Am J Opthalmol, 1971; 71(3): 666-673.
`
`7. Fries J, Bloch DA, Spitz P. “Cancer in rheumatoid arthritis: a prospective long-term study of
`mortality.” Am J Med, 1985; 78: 56-59.
`
`8. Fries J, Bloch DA, Sharp J, McShane D, Patricia S, Gilbert B, Forrester D, Genant H, Gofton
`P, Richman S, Weissman B, Wolfe F. “Assessment of radiological progression in
`rheumatoid arthritis: a randomized controlled trial.” Arthritis Rheum, 1986; 29(1): 1-9
`
`9. Sherrer Y, Bloch DA, Mitchell D, Young D, Fries J. “The development of disability in
`rheumatoid arthritis.” Arthritis Rheum, 1986; 29(4): 494-500.
`
`10. Mitchell D, Spitz P, Young D, Bloch DA, McShane DJ, Fries JF. “Survival, prognosis, and
`cause of death in rheumatoid arthritis.” Arthritis Rheum, 1986; 29: 706-714.
`
`11. Lane N, Bloch DA, Jones H, Marshall W, Wood PD, Fries JF. “Long-distance running, bone
`density, and osteoarthritis.” J Am Med Assoc, 1986; 255(9): 1147-1151.
`
`12. Fries J, Spitz P, Mitchell D, Roth S, Wolfe F, Bloch DA “Impact of specific therapy upon
`rheumatoid arthritis.” Arthritis Rheum, 1986; 29(5): 620-627.
`
`13. Bloch DA “Sample size requirements and the cost of a randomized clinical trial with
`repeated measurements.” Stat Med, 1986; 5(6): 663-667.
`
`3
`
`

`

`14. Altman R, Asch E, Bloch DA, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD
`Greenwald R, Hochberg M, Howell D, Kaplan D, Koopman W, Longley S, Mankin D,
`McShane DJ, Medsger T, Meenan R, Mikkelsen W, Moskowitz R, Murphy W, Rothschild
`B, Segal M, Sokoloff L, Wolfe R. “Development of criteria for the classification and
`reporting of osteoarthritis; classification of osteoarthritis of the knee.” Arthritis Rheum,
`1986; 29(8): 1039-1049.
`
`15. Sherrer Y, Bloch DA, Strober S, Fries J. “Comparative toxicity of total lymphoid irradiation
`and immunosuppressive drug treated patients with intractable rheumatoid arthritis.” J
`Rheumatol, 1987; 14(1): 46-51.
`
`16. Lane N, Bloch DA, Wood PD, Fries JF. “Aging, long-distance running, and the
`development of musculoskeletal disability.” Am J Med, 1987; 82: 772-780.
`
`17. Sherrer YS, Bloch DA, Mitchell DM, Roth SH, Wolfe F, Fries JF. “Disability in rheumatoid
`arthritis: comparison of prognostic factors across three populations.” J Rheumatol, 1987;
`14(4): 705-709.
`
`18. Altman R, Bloch DA, Bole G, Brandt K, Cooke D, Greenwald R, Hochberg M, Howell D,
`Kaplan D, Koopman W, McShane DJ, Mankin H, Medsger T, Meenan R, Mikkelsen W,
`Moskowitz R, Murphy W, Sokoloff L. “Development of clinical criteria for osteoarthritis.” J
`Rheumatol, 1987; 14: 3-6.
`
`19. Altman R, Fries J, Bloch DA, Carstens J, Cooke T, Genant H, Gofton P, Groth H, McShane
`D, Murphy W, Sharp J, Spitz P, Williams C, Wolfe F. “Radiographic assessment of
`progression in osteoarthritis.” Arthritis Rheum, 1987; 30(11): 1214-1224.
`
`20. Bloch DA, Moses LE. “Non-optimally weighted least squares.” Am Statistician, 1988;
`42(1): 50-53.
`
`21. Fries JF, Bloch DA, Segal MR, Spitz PW, Williams C, Lane N. “Post-marketing
`surveillance in rhuematology: analysis of purpura and upper abdominal pain.” J Rheumatol,
`1988; 15(2): 348-355.
`
`22. Arnett F, Edworthy S, Bloch DA, McShane D, Fries J, Cooper N, Healey L, Kaplan S,
`Liang M, Luthra H, Medsger T, Mitchell D, Neustadt D, Pinals R, Schaller J, Sharp J,
`Wilder R, Hunder G. “The American Rheumatism Association 1987 revised criteria for the
`classification of rheumatoid arthritis.” Arthritis Rheum, 1988; 31(3): 315-324.
`
`23. Jariwalla, Sabin R, Lawson S, Bloch DA, Prender M, Andrews V, Herman Z. “Effects of
`dietary phytic acid (phytate) on the incidence of growth rate of tumors promoted in Fisher
`rats by a magnesium supplement.” Nutr Res, 1988; 8: 813-827.
`
`24. Kraemer H, Bloch DA “Kappa coefficients in epidemiology: an appraisal of a reappraisal.”
`J Clin Epidemiol, 1988; 41(10): 959-968.
`
`25. Edworthy S, Zatarain E, McShane D, Bloch DA. “Analysis of the 1982 ARA lupus criteria
`data set by recursive partitioning methodology: new insights into the relative merit of
`individual criteria.” J Rheumatol, 1988; 15(10): 1493 – 1498.
`
`4
`
`

`

`26. Fries J, Miller S, Spitz P, Williams C, Hubert H, Bloch DA “Toward an epidemiology of
`gastropathy associated with non-steroidal anti-inflammatory drug
`(NSAID) use.”
`Gastroenterology, 1989; 96: 647-655.
`
`27. Edworthy S, Bloch DA, McShane D, Segal M, Fries J. “A state model of renal function in
`SLE: its value in the prediction of outcome in 292 subjects.” J Rheumatol, 1989; 16(1): 29-
`35.
`
`28. Fries JF, Singh G, Bloch DA, Colin A. “The natural history of ankylosing spondylitis: is the
`disease really changing?” J Rheumatol, 1989; 16: 860-863
`
`29. Schurman DJ, Bloch DA, Segal M, Tanner C. “Conventional cemented total hip
`arthroplasty: assessment of clinical factors associated with revision for mechanical failure.”
`Clin Orthop, 1989; 240: 173-180.
`
`30. Bloch DA, Kraemer H. “2x2 kappa coefficients: measures of agreement or association.”
`Biometrics, 1989; 45(1): 269-287.
`
`31. Segal M, Bloch DA “A comparison of estimated proportional hazards models and regression
`trees.” Stat Med, 1989; 8(5): 539-550.
`
`32. Lane N, Bloch DA, Jones H, Simpson V, Fries J. “Osteoarthritis in the hand: a comparison
`of handedness and hand use.” J Rheumatol, 1989; 16(5): 637-642.
`
`33. Wysenbeek A, Bloch DA, Fries J. “Prevalence and expression of photosensitivity in
`systemic lupus erythematosus.” Ann Rheum Dis, 1989; 48: 461-463.
`
`34. Bloch DA, Segal M. “Empirical comparison of approaches to forming strata: using
`classification trees to adjust for covariates.” J Am Stat Assoc, 1989; 84(408): 897-905.
`
`35. Lyon M, Bloch DA, Hollack B, Fries J. “Predisposing factors in polymyositis-
`dermatomyositis: results of a nation-wide survey.” J Rheumatol, 1989; 16(9): 1218-1224.
`
`36. Michel B, Bloch DA, Fries J. “Weight-bearing exercise, over exercise and lumbar bone
`density over age 50 years.” Arch Intern Med, 1989; 149: 2325-2329.
`
`37. Kraemer H, Bloch DA “A note on case-control sampling to estimate kappa coefficients.”
`Biometrics, 1990; 46(1): 49-59.
`
`38. Fries JF, Spitz PW, Williams CA, Bloch DA, Singh G, Hurbert HB. “A toxicity index for
`comparison of side effects among different drugs.” Arthritis Rheum, 1990; 33(1): 121-130.
`
`39. Fries JF, Miller SR, Spitz PW, Williams CA, Hubert HB, Bloch DA. “Identification of
`patients at risk for gastropathy associated with NSAID use.” J Rheumatol, 1990; 17(20): 12-
`19.
`
`40. Lane N, Bloch DA, Hubert H, Jones H, Simpson U, Fries JF. “Running, osteoarthritis, and
`bone density: initial two-year longitudinal study.'“ Am J Med, 1990; 88: 452-459.
`
`41. Maloney W, Schurman D, Hangen D, Goodman S, Edworthy S, Bloch DA “The influence
`of continuous passive motion in total knee arthroplasty.” Clin Orthop, 1990; 256: 162-168.
`
`5
`
`

`

`42. Michel B, Lane N, Jones H, Fries J, Bloch DA “Plain radiographs can be useful in
`estimating lumbar bone density.” J Rheumatol, 1990; 17: 528-531.
`
`43. Bloch DA, Moses LE, Michel BA. “Statistical approaches to classification: methods for
`developing classification and other criteria rules.” Arthritis Rheum, 1990; 33(8): 1137-1144.
`
`44. Arend WP, Michel BA, Bloch DA, Hunder G, Calabrese LH, Edworthy SM, Fauci AS,
`Leavitt RY, Lie JT, Lightfoot RW, Masi AT, McShane DJ, Mills JA, Stevens MB, Wallace
`SL, Zvaifler NJ. “The American College of Rheumatology 1990 criteria for the
`classification of Takayasu arteritis.” Arthritis Rheum, 1990; 33(8): 1129-1134.
`
`45. Bloch DA, Michel BA, Hunder GG, McShane D, Arend WP, Calabrese LH, Edworthy SM,
`Fauci AS, Fries JF, Leavitt RY, Lie JT, Lightfoot RW, Masi AT, Mills JA, Stevens MB,
`Wallace SL, Zvaifler NJ. “The American College of Rheumatology 1990 classification of
`vasculitis: patients and methods.” Arthritis Rheum, 1990; 33(8): 1068-1073.
`
`46. Calabrese LH, Michel BA, Bloch DA, Arend W, Edworthy SM, Fauci AS, Fries JF, Hunder
`GG, Leavitt RY, Lie JT, Lightfoot RW, Masi AT, McShane DJ, Mills JA, Stevens MB,
`Wallace SL, Zvaifler NJ. “The American College of Rheumatology 1990 criteria for the
`classification of hypersensitivity vasculitis.” Arthritis Rheum, 1990; 33(8): 1108- 1113.
`
`47. Hunder GG, Arend WP, Bloch DA, Calebrese LH, Fauci AS, Fries JF, Leavitt RY, Lie JT,
`Lightfoot RW, Masi AT, McShane DJ, Michel BA, Mills JA, Stevens MB, Wallace SL,
`Zvaifler NJ. “The American College of Rheumatology 1990 criteria for the classification of
`vasculitis: introduction.” Arthritis Rheum, 1990; 33(8): 1065-1067.
`
`48. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM,
`Fauci AS, Leavitt RY, Lie JT, Lightfoot RW, Masi AT, McShane DJ, Mills JA, Wallace SL,
`Zvaifler NJ. “The American College of Rheumatology 1990 criteria for the classification of
`giant cell arteritis.” Arthritis Rheum, 1990; 33(8): 1122—1128.
`
`49. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese LH, Fries
`JF, Lie JT, Lightfoot RW, Masi AT, McShane DJ, Mills JA, Stevens MB, Wallace SL,
`Zvaifler NJ. “The American College of Rheumatology 1990 criteria for the classification of
`Wegener's Granulomatosis.” Arthritis Rheum, 1990; 33(8): 1101-1107.
`
`50. Lie JT, and Members and Consultants of the American College of Rheumatology
`Subcommittee on Classification of Vasculitis. “Illustrated histopathologic classification
`criteria for selected vasculitis syndromes.” Arthritis Rheum, 1990; 33(8): 1074-1087.
`
`51. Lightfoot RW, Michel BA, Bloch DA, Hunder G, Zvaifler NJ, McShane DJ, Arend WP,
`Calabrese LH, Leavitt RY, Lie JT, Masi AT, Mills JA, Stevens MB, Wallace SL. “The
`American College of Rheumatology 1990 criteria for the classification of polyarteritis
`nodosa.” Arthritis Rheum, 1990; 33(8): 1088-1093.
`
`52. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy
`SM, Fauci AS, Leavitt RY, Lightfoot RW, McShane DJ, Mills JA, Stevens MB, Wallace
`SL, Zvaifler NJ. “The American College of Rheumatology 1990 criteria for the
`classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis).” Arthritis
`Rheum, 1990; 33(8): 1094-1100.
`
`6
`
`

`

`53. Mills JA, Michel BA, Bloch DA, Calebrese HL, Hunder GG, Arend WP, Edworthy SM,
`Fauci AS, Leavitt RY, Lie JT, Lightfoot RW, Masi AT, McShane DJ, Stevens MB, Wallace
`SL, Zvaifler NJ. “The American College of Rheumatology 1990 criteria for the
`classification of Henoch-Schonlein purpura.” Arthritis Rheum, 1990; 33(8): 1114-1121.
`
`54. Fries JF, Hunder GG, Bloch DA, Michel B, Arend WP, Calabrese LH, Fauci AS, Leavitt
`RY, Lie JT, Lightfoot RW, Masi AT, McShane DJ, Mills JA, Stevens MB, Wallace SL,
`Zvaifler NJ. “The American College of Rheumatology 1990 criteria for the classification of
`vasculitis: summary.” Arthritis Rheum, 1990; 33(8): 1135-1136.
`
`55. Altman R, Alarcon G, Appelrouth D, Bloch DA, Borenstein D, Brandt K, Brown C, Cooke
`TD, Daniel W, Gray R, Greenwald R, Hochberg M, Howell D, Ike R, Kapila P, Kaplan D,
`Koopman W, Longley S, McShane DJ, Medsger T, Michel B, Murphy W, Osial T, Ramsey-
`Goldman R, Rothschild B, Stark K, Wolfe F. “The American College of Rheumatology
`criteria for classification and reporting of osteoarthritis of the hand.” Arthritis Rheum, 1990;
`33(11): 1601-1610.
`
`56. Singh G, Fries JF, Williams CA, Zatarain E, Spitz P, Bloch DA.. “Toxicity profiles of
`disease modifying antirheumatic drugs in rheumatoid arthritis.” J Rheumatol, 1991; 18(2):
`188-194.
`
`57. Wachter R, Russi M, Bloch DA, Hopewell P, Luce J. “Pneumocystis carinii pneumonia and
`respiratory failure in AIDS: improved outcomes and increased use of intensive care units.'“
`Am Rev Respir Dis, 1991; 143: 251-256.
`
`58. Altman R, Medsger T, Bloch DA, Michel B. “Predictors of survival in systemic sclerosis
`(scleroderma).” Arthritis Rheum, 1991; 34(4): 403-413.
`
`59. Altman R, Alarcon G, Appelrouth D, Bloch DA, Borenstein D, Brandt K, Brown C, Cooke
`TD, Daniel W, Feldman D, Greenwald R, Hochberg M, Howell D, Ike R, Kapila P, Kaplan
`D, Koopman W, Marino C, McDonald E, McShane DJ, Medsger T, Michel B, Murphy WA,
`Osial T, Ramsey-Goldman R, Rothschild B, Wolfe F. “The American College of
`Rheumatology criteria for classification and reporting of osteoarthritis of the hip.” Arthritis
`Rheum, 1991; 34(5): 505-514.
`
`60. Michel B, Bloch DA, Fries J. “Predictors of fractures in early rheumatoid arthritis.” J
`Rheumatol, 1991; 18(6): 804-808.
`
`61. Sharp J, Wolfe F, Mitchell D, Bloch DA. “The progression of erosion and joint space
`narrowing scores in RA during the first twenty-five years of disease.” Arthritis Rheum,
`1991; 34(6): 660-668.
`
`62. Fries JF, Spitz PW, Bloch DA, Williams CA. “Factors in the duration and discontinuation
`of treatment with non steroidal anti-inflammatory medications.” Clin Ther, 1991; 13(A):
`51-62.
`
`63. Fries JF, Williams CA, Bloch DA, Michel BA. “NSAID-associated gastropathy: incidence
`and risk factor models.” Am J Med, 1991; 91(3): 213-222.
`
`7
`
`

`

`64. Fries JF, Williams CA, Bloch DA. “The relative toxicity of non-steroidal anti-inflammatory
`drugs.” Arthritis Rheum, 1991; 34(11): 1353-1360.
`
`65. Redelmeier D, Bloch DA, Hickam D. “Assessing predictive accuracy: how to compare
`Brier scores.” J Clin Epidemiol, 1991; 44(11): 1141-1146.
`
`66. Michel B, Bloch DA, Lane N, Fries J. “Effect of changes in weight-bearing exercise on
`lumbar bone mass after age fifty”, Ann Med, 1991; 23: 397-401.
`
`67. Michel B, Bloch DA, Fries J. “Physical activity and fractures after age 50.” Int Orthop,
`1992; 16: 87-91.
`
`68. Michel BA, Hunder GG, Bloch DA, Calabrese LH. “Hypersensitivity vasculitis and
`Henoch-Schoenlein purpura: a comparison between the two disorders.” J Rheumatol, 1992;
`19(5): 721-728.
`
`69. Callahan LF, Bloch DA, Pincus T. “Identification of work disability in rheumatoid arthritis:
`physical, radiographic and laboratory variables do not add explanatory power to
`demographic and functional variables.” J Clin Epidemiol, 1992; 45(2): 127-138.
`
`70. Michel BA, Lane NE, Bjorkengren A, Bloch DA, Fries JF. “Impact of running on lumbar
`bone density: A 5-year longitudinal study.” J Rheumatol, 1992; 19(11): 1759-1763.
`
`71. Michel B, Fries J, Bloch DA, Lane N, Jones H. “Osteophytosis of the knee: associations
`with changes in weight-bearing exercise.” Clin Rheumatol, 1992; 11(2): 235-238.
`
`72. Edworthy S, Bloch DA, Brant R, Fries J. “Detecting treatment effects in patients with
`rheumatoid arthritis: the advantages of longitudinal data.” J Rheumatol, 1993; 20(1): 40-44.
`
`73. Michel BA, Bjorkengren AG, Lambert E, Lane NE, Fries JF, Bloch DA. “Estimating lumbar
`bone mineral density from routine radiographs of the lumbar spine.” Clin Rheumatol, 1993;
`12(1): 49-52.
`
`74. Hubert H, Bloch DA, Fries J. “Risk factors for physical disability in an aging cohort: the
`NHANES I epidemiologic followup study.” J Rheumatol, 1993; 20(3): 480-488.
`
`75. Lane N, Michel B, Bjorkengren A, Oehlert J, Shi H, Bloch DA, Fries J. “The risk of
`osteoarthritis with running and aging: a five year longitudinal study.” J Rheumatol, 1993;
`20(3): 461-468.
`
`76. Fries J, Williams C, Ramey D, Bloch DA. “The relative toxicity of disease-modifying
`antirheumatic drugs.” Arthritis Rheum, 1993; 36(3): 297-306.
`
`77. Fries JF, Bloch DA, Harrington H, Richardson N, Beck R. “Two-year results of a
`randomized controlled trial of a health promotion program in a retiree population: The Bank
`of America study.” Am J Med, 1993; 94(5): 455-462.
`
`78. Belmonte MA, Bloch DA, Lane NE, Michel BE, Fries JF. “The relationship between spinal
`and peripheral osteoarthritis and bone density measurements.” J Rheumatol, 1993; 20(9):
`1005-1013.
`
`8
`
`

`

`79. Raynauld JP, Bloch DA, Fries JF. “Seasonal variation in the onset of Wegener's
`granulomatosis, polyarteritis nodosa and giant cell arteritis.” J Rheumatol, 1993; 20(9):
`1524-1526.
`
`80. Bloch GJ, Butler PC, Kohlert J G, Bloch DA. “Microinjection of galanin into the medial
`preoptic nucleus facilitates copulatory behavior in the male rat.” Physiol Behav, 1993; 54:
`615-624.
`
`81. Astion ML, Wener MH, Thomas RG, Hunder GG, Bloch DA. “Over training in neural
`networks that interpret clinical data.” Clin Chem, 1993; 39(9): 1998-2004.
`
`82. Michel BA, Bloch DA, Wolfe F, Fries JF. “Fractures in rheumatoid arthritis: An evaluation
`of associated risk factors.” J Rheumatol, 1993; 20(10): 1666-1669.
`
`83. Clarke A, Esdaile J, Bloch DA, Lacaille D, Danoff D, Fries J.F. “A Canadian study of the
`total medical costs for patients with systemic lupus erythematosus and the predictors of
`costs.” Arthritis Rheum, 1993; 36(11): 1548-1559.
`
`84. Fries JF, Ramey DR, Singh G, Morfeld D, Bloch DA, Raynauld JP. “A re-evaluation of
`aspirin therapy in rheumatoid arthritis.” Arch Intern Med, 1993; 153: 2465-2471.
`
`85. Fries JF, Williams CA, Ramey DR, Bloch DA. “The relative toxicity of alternative
`therapies for rheumatoid arthritis: implications for the therapeutic progression.” Semin
`Arthritis Rheum, 1993; 23: 68-73.
`
`86. Kitchell BE, Brown DM, Luck EE, Woods L, Orenberg EK, Bloch DA. “Intralesional
`therapeutic implant for the treatment of primary oral malignant melanoma in the dog.” J Am
`Vet Med Assoc, 1994; 204(2): 229-236.
`
`87. Lacaille D, Clarke AE, Bloch DA, Danoff D, Esdaile JM. “The impact of disease activity,
`treatment and disease severity on short-term costs of systemic lupus erythematosus.” J
`Rheumatol, 1994; 21(3): 448- 453.
`
`88. Wolfe F, Mitchell D, Sibley J, Fries J, Bloch DA, Williams C, Spitz P, Haga M, Kleinheksel
`S, Cathey M. “The mortality of rheumatoid arthritis.” Arthritis Rheum, 1994; 37(4): 481-
`494.
`
`89. Astion ML, Wener MH, Thomas RG, Hunder GG, Bloch DA. “Application of neural
`networks to the classification of giant cell arteritis.” Arthritis Rheum, 1994; 37(5): 760-770.
`
`90. Winograd CH, Lemsky CM, Nevitt MC, Nordstrom TM, Stewart AL, Miller CJ, Bloch DA.
`“Development of a physical performance and mobility examination.” J Am Geriatr Soc,
`1994; 42(7): 743- 749.
`
`91. Clarke AE, Bloch DA, Esdaile JM. “Decreasing costs and improving outcomes in SLE:
`Using regression trees to develop health policy.” J Rheumatol, 1994; 21(12): 2246-2253.
`
`92. Ward MM, Hubert HB, Shi H, Bloch DA, “Physical disability in older runners: prevalence,
`risk factors, and progression with age.” J Gerontol: Med Sci; 1995; 50A(2): M70-M77.
`
`9
`
`

`

`93. Hornberger JC, Habraken H, Bloch DA. “Minimum data needed on patient preferences for
`accurate, efficient medical decision making.” Med Care, 1995; 33(3): 297-310.
`
`94. Tubert-Bitter P, Bloch DA, Raynauld JP. “Comparing the bivariate effects of toxicity and
`efficacy of treatments.” Stat Med, 1995; 14: 1129-1141.
`
`95. Rubin GD, Alfrey EJ, Dake MD, Semba CP, Sommer FG, Kuo PC, Dafoe DC, Waskerwitz
`JA, Bloch DA, Jeffrey RB. “Assessment of living renal donors with spiral CT.” Radiology,
`1995; 195(2): 457-462.
`
`96. Poole JL, Williams CA, Bloch DA, Hollak B, Spitz P. “Concurrent validity of the health
`assessment questionnaire disability index in seleroderma.” Arthritis Care Res, 1995; 8(3):
`189-193.
`
`97. Singer AH, Tsao PS, Wang BY, Bloch DA, Cooke JP. “Discordant effects of dietary L-
`arginine on vascular structure and reactivity in hypercholesterolemic rabbits.” J Cardiovasc
`Pharmocol, 1995; 25(5): 710-716.
`
`98. Clarke AE, Bloch DA, Medsger TA, Oddis CV. “A longitudinal study of functional
`disability in a national cohort of patients with polymyositis - dermatomyositis.” Arthritis
`Rheum, 1995; 38(9): 1218-1224
`
`99. Matteson EL, Gold KN, Bloch DA, Hunder GG. “Long term survival of patients with giant
`cell arteritis from the American College of Rheumatology giant cell arteritis classification
`criteria cohort.” Am J Med, 1996; 100: 193-196.
`
`100. Williams CA, Bloch DA, Sibley J, Haga M, Wolfe F, Reynauld JP, Singh G, Hickey AR,
`Fries JF. “Lymphoma and Leukemia in rheumatoid arthritis: are they associated with
`azathioprine, cyclophosphamide, or methotrexate?: A matched case - control study in the
`ARAMIS population.” J Clin Rheumatol, 1996; 2(2): 64-72.
`
`101. Terr LC, Bloch DA, Michel BA, Shi H, Reinhardt JA, Metayer S. “Children's memories in
`the wake of Challenger.” Am J Psychiatry, 1996; 153(5): 618-625.
`
`102. Terr AI, Bloch D A, “Trends in asthma therapy in the United States: 1965-1992.” Ann
`Allergy Asthma Immunol, 1996; 76: 273-281.
`
`103. Hornberger JC, Gibson CD, Wood W, Dequeldre C, Corso I, Palla B, Bloch DA.
`“Eliminating language barriers for non-English-speaking patients: a randomized control
`trial.” Med Care, 1996; 34(8): 845-856.
`
`104. James KE, Bloch DA, Lee KK, Kraemer HC, Fuller RF. “An index for assessing blindness
`in a multicenter clinical trial: disulfiram for alcohol cessation.” Stat Med, 1996; 15(13):
`1421-1434.
`
`105. Gironimi G, Clarke AE, Hamilton VH, Danoff DS, Bloch DA, Fries JF, Esdaile JM. “Why
`health care costs more in the U.S.: comparing health care expenditures between SLE patients
`at Stanford and Montreal.” Arthritis Rheumatol, 1996; 39(6): 979-987.
`
`10
`
`

`

`106. Matteson EL, Gold KN, Bloch DA, Hunder GG. “Long term survival of patients with
`Wegener's granulomatosis from the American College of Rheumatology Wegener's
`granulomatosis classification criteria cohort.” Am J Med, 1996; 101: 129-134.
`
`107. Satish S, Winograd CH, Chavez C, Bloch DA. “Geriatric targeting criteria as predictors of
`survival and health care utilization.” J Am Geriatr Soc, 1996; 44: 914-921.
`
`108. Bonello RS, Marcus R, Bloch DA, Strober S. “Effects of growth hormone and estrogen on T
`lymphocytes in older women.” J Am Geriatr Soc, 1996; 44: 1038-1042.
`
`109. Sevin BU, Nadji M, Lu Y, Bloch DA, Koechli OR, Averette HA. “Surgically defined
`prognostic parameters in patients with early cervical carcinoma: a multivatiate survival tree
`analysis.” Cancer, 1996; 78: 1438-1446.
`
`110. Rubin GD, Lane ML, Bloch DA, Leung AN, Stark P. “Optimization of thoracic spiral CT:
`effects of iodinated contrast medium concentration.” Radiology, 1996; 201: 785-791.
`
`111. Altman RD, Brandt K, Hochberg MC, Moskowitz R, Bellamy N, Bloch DA, et al. “Design
`and conduct of clinical trials in patients with osteoarthritis: recommendations from a task
`force of the Osteoarthritis Research Society.” Osteoarthritis Cartilage, 1996; 4: 217-243.
`
`112. Bloch DA, Silverman BW. “Monotone discriminant functions and their applications in
`rheumatology.” J Am Stat Assoc, 1997; 92: 144-153.
`
`113. Bloch DA. “Comparing two diagnostic tests against the same “gold standard” in the same
`sample.” Biometrics, 1997; 53: 73-85.
`
`114. Vosti KL, Bloch DA, Jacobs CD. “The relationship of clinical knowledge to months of
`clinical training among medical students.” Acad Med, 1997; 72: 305-307.
`
`115. Carmeci C, DeConinck EC, Lawton T, Bloch DA, Weigel RJ. “Analysis of estrogen
`receptor messenger RNA in breast carcinomas from archival specimens is predictive of
`tumor biology.” Am J Pathol, 1997; 150: 1563-1570.
`
`116. Winograd CH, Lindenberger EC, Chavez CM, Mauricio MP, Shi H, Bloch DA. “Identifying
`hospitalized older patients at varying risk for physical performance decline: a new
`approach.” J Am Geriatr Soc, 1997; 45: 604-609.
`
`117. Terr LC, Bloch DA, Michel BA, Shi H, Reinhardt JA, Metayer S. “Children's thinking in the
`wake of Challenger.” Am J Psychiatry, 1997; 154(6): 744-751.
`
`118. Nelson LM, Bloch DA, Longstreth WT, Shi H. “Recursive partitioning for the identification
`of disease risk subgroups: a case - control study of subarachnoid hemorrhage.” J Clin
`Epidemiol, 1998; 51(3): 199-209.
`
`119. Hirsch R, Fernandes RJ, Pillemer SR, Hochberg MC, Lane NE, Altman RD, Bloch DA,
`Knowler WC, Bennet PH. “Hip osteoarthritis prevalence estimates by three radiographic
`scoring systems.” Arthritis Rheum, 1998; 41(2): 361-368.
`
`11
`
`

`

`120. Lane NE, Oehlert JW, Bloch DA, Fries JF. “The relationship of running with osteoarthritis
`of the knee and hip and bone mineral density of the lumbar spine: a nine year longitudinal
`study.” J Rheum, 1998; 25(2): 334-341.
`
`121. Inserra MM, Bloch DA, Terris DJ. “Functional indices for sciatic, peroneal and posterior
`tibial nerve lesions in the mouse.” Microsurgery, 1998; 18: 119-124.
`
`122. Hsieh FY, Bloch DA, Larsen MD. “A simple method of sample size calculation for linear
`and logistic regression.” Stat Med, 1998; 17: 1623-1634.
`
`123. Hirsch R, Lin J-P, Scott WW, Ma LD, Pillemer SR, Kastner DL, Jacobsson LTH, Bloch
`DA, Knowler WC, Bennet PH, Bale SJ. “Rheumatoid arthritis in the Pima indians: the
`intersection of epidemiologic, demographic and genealogic data.” Arthritis Rheum, 1998;
`41(8): 1464-1469.
`
`124. Wolff DR, Rose J, Jones VK, Bloch DA, Oehlert JW, Gamble JG. “Postural balance
`measurements for children and adolescents.” J Orthop Res, 1998; 16:271-275.
`
`125. Schurman DJ, Matityahu A, Goodman SB, Maloney W, Woolson S, Shi H, Bloch DA.
`“Prediction of post-operative knee flexion in Insall-Burstein-11 total knee arthoplasty.” Clin
`Orthop, 1998; 353: 175-184.
`
`126. Hayamizu K, Zeng D, Huie P, Garcia-Ojeda ME, Bloch DA, Fong L, Engeleman EG, Sibley
`RK, Strober S. “Donor blood monocytes but not T or B cells facilitate long-term allograft
`survival after total lymphoid irradication.” Transplantation, 1998; 66(5): 585-593.
`
`127. Gabalski EC, Adam M, Pinto H, Brown JM, Bloch DA, Terris DJ. “Pretreatment and mid-
`treatment measurements of oxygen tension levels in head and neck cancers.” Laryngoscope,
`1998; 108: 1856- 1860.
`
`128. Adam MF, Gabalski EC, Bloch DA, Oehlert JW, Brown JM, Elsaid AA, Pinto HA, Terris
`DJ. “Tissue oxygen distribution in head and neck cancer patients.” Head Neck, 1999; 21:
`146-153.
`
`129. Calkins H, Yong P, Miller JM, Olshansky B, Carlson M, Saul JP, Shoei K, Huang S, Liem
`LB, Klein LS, Moser SA, Bloch DA, Gillette P, Prystowsky E. “Catheter ablation of
`accessory pathways, atrioventricular nodal reentant tachycardia, and the atrioventricular
`junction: final results of a prospective multi-center clinical trial.” Circulation, 1999; 99:
`262-270.
`
`130. Thom DH, Bloch DA, Segal ES. “An intervention to increase patients' trust in their
`physicians, Stanford Trust Study Group.” J Acad Med, 1999; 74(2): 195-198.
`
`131. Rosen A, Gamble JG, Vallier H, Bloch DA, Smith L, Rinsky LA. “Analysis of radiographic
`measurement as prognostic indicators of treatment success in patients with developmental
`dysplasia of the hip.” J Pediatr Orthop B, 1999; 8: 118-121.
`
`132. Hornberger J, Bloch DA, Hlatky M, Baumgartner W. “Patient preferences in coronary
`revascularization.” Am Heart J, 1999; 137: 1153-1162.
`
`12
`
`

`

`133. Lavori PW, Bloch DA, Bridge PT, Leiderman DB, LoCastro JS, Somoza E. “Plans, designs
`and analyses for clinical trials of anti-cocaine medications: where we are today.” J Clin
`Psychopharmacol, 1999; 19(3): 246-256.
`
`134. Fischer D, Stewart AL, Bloch DA, Lorig K, Laurent D, Holman H. “Capturing the patient's
`view of change as a clinical outcome measure.” JAMA, 1999; 282(12): 1157-1162.
`
`135. Terr LC, Bloch DA, Michel BA, Shi H, Reinhardt JA, Matayer S. “ Children's symptoms in
`the wake of Challenger: a field study of distant-tramatic effects and an outline of related
`conditions.” Am J Psychiatry, 1999; 156: 1536-1544.
`
`136. Schwartz AV, Villa ML, Prill M, Kelsey JA, Galinus JA, Delay RR, Nevitt MC, Bloch DA,
`Marcus R, Kelsey JL. “Falls in older Mexican-American women.” J Am Geriatr Soc, 1999;
`47: 1371-1378.
`
`137. Dorie MJ, Kovacs MS, Gabalski EC, Adam M, Le QT, Bloch DA, Pinto HA, Terris DJ,
`Brown MJ. “DNA damage by the comet assay in head and neck cancer patients treated with
`tirapazamine.” Neoplasia, 1999; 1(5): 461-467.
`
`138. Altman RD, Bloch DA, Hochberg MC, Murphy WA. “Prevalence of pelvic Paget's disease
`of bone in the United States.” J Bone Miner Res, 2000; 15: 461-465.
`
`139. Chitkara U, Lee L, El-Sayed Y, Holbrook RH, Bloch DA, Oehlert JW, Druzin ML.
`“Ultrasonographic ear length measurement in normal second - and third - trimester fetus